(All times listed in ET*)
Wednesday, November 29: 3:00 PM - 6:00 PM
Thursday, November 30: 6:30 AM - 5:30 PM
Friday, December 1: 6:30 AM - 5:15 PM
Saturday, December 2: 6:30 AM - 4:30 PM
Sunday, December 3: 6:30 AM - 12:15 PM
Agenda is subject to change.
Use the Advanced Filter below to identify the tracks that are of interest.
*All Credits are pending approval for COPE, FL Board Optometry, FL Board Opticianry, TX Board of Optometry.
*Note: The CEE, or Transcript Quality (TQ), courses are noted by the (CEE) tag. You can sort by this tag under Advanced Filters.
FL Board of Optometry: 20-1116780
TX Board- Optometry: 20-1122446
This session will explore the different perspectives of two different health professionals on myopia and myopia management – also from an international standpoint – and will discuss ways to bridge the gap between the perspectives.
FL Board Optometry: 20-1116852
TX Board- Optometry: 20-1122448
TX Board- Optometry: 20-1122452
Ocular hypertension is generally thought of a precursor to glaucoma. The understanding of various risk factors through the Ocular Hypertension Treatment Study (OHTS) is fundamental to our treatment and management of this condition. With the advent of Optical Coherence Tomography (OCT) we gained further insight into effective management of this ocular hypertension. The clinical paradigm has shifted over the years in what testing to perform, how frequently patients need to be seen, and when to initiate as well as escalate treatment. In this course we will review the proper definition, causes and most up-to-date treatment and management of ocular hypertension.
TX Board- Optometry: 20-1123812
Scleral lens fitting has become very popular, although differences between different parts of the world exists. This session covers the latest research from an evidence-based perspective, to see what is says about scleral lenses: its efficacy and safety (the science). It furthermore covers basic scleral lens fitting considerations.
TX Board- Optometry: 20-1122454
Optometrists remain the first line of defense for the majority of glaucoma suspects and glaucoma patients that prevent for comprehensive exams. With the advent of new medications over the last five years and the number of patients with glaucoma increasing as baby boomers are getting older, it is imperative to understand the medication profiles including side effects and potential adverse effects with glaucoma medications especially given several co-morbidities that may be present in this patient population. Rather than having a one size fits all approach, it is important to decide a treatment plan on an individual basis. In this course we will review the mechanisms of actions of the medications, proper techniques in measuring intraocular pressure and both the conventional and unconventional drainage systems of aqueous humor. We will go through several clinical cases to enhance understanding using real-life examples.